Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NAB1 | Human | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of NAB1 mRNA | CTD | PMID:23649840 | NAB1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NAB1 mRNA | CTD | PMID:36331819 | NAB1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAB1 mRNA | CTD | PMID:22206623 | NAB1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Nab1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of NAB1 mRNA | CTD | PMID:22206623 | NAB1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NAB1 mRNA | CTD | PMID:31614463 | NAB1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NAB1 mRNA | CTD | PMID:19770486 | NAB1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NAB1 mRNA | CTD | PMID:33387578 and PMID:34747641 | NAB1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nab1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NAB1 mRNA | CTD | PMID:21570461 and PMID:24680724 | NAB1 | Human | 2-ethoxyethanol | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | 2-ethoxyethanol results in increased expression of NAB1 mRNA | CTD | PMID:19643169 | NAB1 | Human | 2-methoxyethanol | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | methyl cellosolve results in increased expression of NAB1 mRNA | CTD | PMID:19643169 | NAB1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of NAB1 mRNA | CTD | PMID:21179406 | NAB1 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAB1 mRNA | CTD | PMID:28628672 | NAB1 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of NAB1 mRNA | CTD | PMID:30951980 | NAB1 | Human | aflatoxin B1 | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of NAB1 mRNA | CTD | PMID:19770486 | NAB1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NAB1 gene | CTD | PMID:27153756 | NAB1 | Human | ammonium chloride | affects expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of NAB1 mRNA | CTD | PMID:16483693 | NAB1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of NAB1 mRNA | CTD | PMID:33212167 | NAB1 | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of NAB1 mRNA | CTD | PMID:19162166 | NAB1 | Human | benzo[a]pyrene | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of NAB1 mRNA | CTD | PMID:22228805 | NAB1 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of NAB1 promoter | CTD | PMID:27901495 | NAB1 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20018196 | NAB1 | Human | bis(2-chloroethyl) sulfide | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of NAB1 mRNA | CTD | PMID:15674843 | NAB1 | Human | bisphenol A | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of NAB1 mRNA | CTD | PMID:25181051 | NAB1 | Human | bisphenol A | decreases expression | ISO | Nab1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of NAB1 mRNA | CTD | PMID:33221593 | NAB1 | Human | bisphenol A | increases methylation | ISO | Nab1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of NAB1 gene | CTD | PMID:28505145 | NAB1 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAB1 mRNA | CTD | PMID:28628672 | NAB1 | Human | bisphenol F | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of NAB1 mRNA | CTD | PMID:30951980 | NAB1 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of NAB1 mRNA | CTD | PMID:38568856 | NAB1 | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of NAB1 protein | CTD | PMID:35688186 | NAB1 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to NAB1 gene] | CTD | PMID:28238834 | NAB1 | Human | chlorpyrifos | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Chlorpyrifos results in decreased expression of NAB1 mRNA | CTD | PMID:18668222 | NAB1 | Human | choline | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NAB1 gene | CTD | PMID:20938992 | NAB1 | Human | cisplatin | affects response to substance | EXP | | 6480464 | NAB1 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | NAB1 | Human | clofibrate | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of NAB1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NAB1 mRNA] | CTD | PMID:17585979 | NAB1 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NAB1 mRNA | CTD | PMID:19376846 | NAB1 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of NAB1 mRNA | CTD | PMID:19549813 | NAB1 | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of NAB1 protein | CTD | PMID:35688186 | NAB1 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of NAB1 mRNA | CTD | PMID:19167446 | NAB1 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of NAB1 mRNA | CTD | PMID:19167446 | NAB1 | Human | cyclosporin A | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of NAB1 mRNA | CTD | PMID:19770486 | NAB1 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAB1 mRNA | CTD | PMID:28628672 | NAB1 | Human | dibutyl phthalate | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of NAB1 mRNA | CTD | PMID:21266533 | NAB1 | Human | dibutyl phthalate | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of NAB1 mRNA | CTD | PMID:21266533 | NAB1 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of NAB1 mRNA | CTD | PMID:28302478 | NAB1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAB1 mRNA | CTD | PMID:27188386 | NAB1 | Human | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of NAB1 mRNA | CTD | PMID:26272509 | NAB1 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAB1 mRNA | CTD | PMID:27188386 | NAB1 | Human | flutamide | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of NAB1 mRNA | CTD | PMID:24136188 | NAB1 | Human | folic acid | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | NAB1 | Human | folic acid | decreases expression | ISO | Nab1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of NAB1 mRNA | CTD | PMID:25629700 | NAB1 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of NAB1 protein | CTD | PMID:37730182 | NAB1 | Human | gentamycin | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of NAB1 mRNA | CTD | PMID:22061828 | NAB1 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of NAB1 mRNA | CTD | PMID:20044591 | NAB1 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAB1 mRNA | CTD | PMID:28628672 | NAB1 | Human | isoprenaline | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB1 mRNA | CTD | PMID:10710348 | NAB1 | Human | ketamine | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of NAB1 mRNA | CTD | PMID:20080153 | NAB1 | Human | L-methionine | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NAB1 gene | CTD | PMID:20938992 | NAB1 | Human | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of NAB1 mRNA | CTD | PMID:20044591 | NAB1 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of NAB1 mRNA | CTD | PMID:26272509 | NAB1 | Human | nefazodone | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of NAB1 mRNA | CTD | PMID:24136188 | NAB1 | Human | paracetamol | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of NAB1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NAB1 mRNA] | CTD | PMID:17585979 | NAB1 | Human | paracetamol | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of NAB1 mRNA | CTD | PMID:33387578 | NAB1 | Human | paracetamol | affects expression | ISO | Nab1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NAB1 mRNA | CTD | PMID:17562736 | NAB1 | Human | pentachlorophenol | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of NAB1 mRNA | CTD | PMID:23892564 | NAB1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NAB1 mRNA | CTD | PMID:36331819 | NAB1 | Human | phenobarbital | increases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Phenobarbital results in increased expression of NAB1 mRNA | CTD | PMID:12082028 | NAB1 | Human | phenylephrine | multiple interactions | ISO | Nab1 (Mus musculus) | 6480464 | [Phenylephrine co-treated with Isoproterenol] results in increased expression of NAB1 mRNA | CTD | PMID:10710348 | NAB1 | Human | pirinixic acid | increases expression | ISO | Nab1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of NAB1 mRNA | CTD | PMID:18301758 | NAB1 | Human | piroxicam | decreases expression | EXP | | 6480464 | Piroxicam results in decreased expression of NAB1 mRNA | CTD | PMID:21858171 | NAB1 | Human | raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of NAB1 mRNA | CTD | PMID:19059307 | NAB1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of NAB1 mRNA | CTD | PMID:19167446 | NAB1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAB1 mRNA | CTD | PMID:27188386 | NAB1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NAB1 mRNA | CTD | PMID:38568856 | NAB1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of NAB1 mRNA | CTD | PMID:31533062 | NAB1 | Human | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of NAB1 mRNA | CTD | PMID:14699072 | NAB1 | Human | tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of NAB1 mRNA | CTD | PMID:19059307 | NAB1 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of NAB1 mRNA | CTD | PMID:31758290 | NAB1 | Human | topotecan | affects response to substance | EXP | | 6480464 | NAB1 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | NAB1 | Human | valproic acid | affects expression | ISO | Nab1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of NAB1 mRNA | CTD | PMID:17963808 | NAB1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NAB1 mRNA | CTD | PMID:24383497 | NAB1 | Human | vinclozolin | affects expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of NAB1 mRNA | CTD | PMID:19015723 | NAB1 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of NAB1 mRNA | CTD | PMID:18356318 | NAB1 | Human | zinc atom | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Zinc deficiency results in decreased expression of NAB1 mRNA | CTD | PMID:12672911 | NAB1 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of NAB1 mRNA | CTD | PMID:18356318 | NAB1 | Human | zinc(0) | decreases expression | ISO | Nab1 (Rattus norvegicus) | 6480464 | Zinc deficiency results in decreased expression of NAB1 mRNA | CTD | PMID:12672911 | NAB1 | Human | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of NAB1 mRNA | CTD | PMID:24714768 | |